Amylose

DB15216InvestigationalSmall molecule

Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial).

Resolves to

Compound
UNII7TDQ74Y18LCAS9005-82-7
Clinical / RWD
RxNorm2709572

What you can answer from here — as of September 20, 2026

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
20+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Amylose, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In